Introduction: Are Health Tests Really a Good Idea? Heart Disease Framingham Heart Study Heart Scans Mosley's Heart Scan Mosley's Diagnosis Plaque Buildup Cancer Tests Over Diagnosis Mosley's PSA Test Bowel Cancer Mosley's Bowel Scope Do It Yourself Genetic Testing Mosley's DNA Results Alzheimer's Report Getting Ahead of Symptoms Screening, a Personal Decision Credits: Are Health Tests Really A Good Idea?
Frontmatter -- Preface -- Contents -- I. Morphology -- Structure and ultrastructure of prolactinomas -- Prolactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones -- Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours -- Hyperplasia of prolactin pituitary cells with or with out microadenoma -- Hormone-secretion in cell culture of microprolacti nomas, periadenomatous tissue and capsules -- Immunocytochemical, ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas -- Immunohìstochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo -- New immunocytochemical observations in prolactinomas -- Problematic divergencies between clinical and immunocytochemical findings in prolactinomas -- Necrosis of prolactinoma cells after bromocriptine treatment -- Spontaneous pituitary lesions and plasma prolactin levels in rats -- II. Radiology -- CT-findings in pituitary adenomas -- Comparative study of normal subjects and cases with microadenoma on high-resolution computed tomography -- III. Endocrinological and clinical aspects -- Actions of dopamine receptor agonists at the pituitary level -- Dopamine and prolactinomas -- Rhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome -- Prolactin responses to thyrotropin-releasing hormone, metoclopramide and insulin-induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients -- Evidence for functional impairment of growth hormone secretion in prolactinoma -- TSH response to dopamine receptor blockade in women with PRL-secreting microadenoma: Long effect of surgical removal -- Prolactin and TSH responses to TRH and domperidone in delayed puberty -- Anterior pituitary function in patients with prolactinomas -- Pituitary adenomas with hyperprolactinaemia in males -- Prolactinoma in multiple endocrine neoplasia type I -- Recurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalized microprolactinomas -- Impairment of pituitary hormone secretion in patients with prolactinoma -- IV. Surgical treatment -- The recurrence of pituitary adenoma -- a management challenge -- Transsphenoidal operations for prolactinomas -- Prolactinomas: surgical results in 96 cases -- Effect of transsphenoidal surgery on pituitary function -- Transsphenoidal microsurgical treatment of 77 prolactinomas -- Review of 56 prolactin-secreting pituitary adenomas -- The effect of transsphenoidal selective microadenomectomy on patients with prolactinomas -- Surgical results and long-term follow-up in female and male prolactinomas -- Otoliquorrhoea in large prolactinomas. Pathomechanism and surgical management -- Invasive prolactinomas in adolescents -- Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas -- Long-term follow-up of prolactinomas. Clinical and morphologic correlation -- Clinicopathologîcal and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas -- V. Pharmacotherapy -- New aspects of medical treatment of prolactinomas -- Conservative management of prolactinoma -- Effect of bromocriptine therapy on large prolactinomas -- Macroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumour calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan -- Evidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma -- The influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly -- Persisting partial suppression of growth hormone excess in acromegaly after long term treatment with bromocriptine -- Medical and surgical treatment of micro and macroprolactinomas: seven years follow-up of 65 cases -- VI. Aspects of gynecology and obstetrics -- Management of prolactinomas in pregnancy -- Long-term follow-up of hyperprolactinaemia in women -- Prophylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies -- Natural regression after pregnancy of a CT visualized microprolactinoma -- Prolactin levels and ovarian function after surgical treatment of prolactinomas -- Pregnancies after treatment of prolactinomas: course and complications -- Psychosomatic findings in patients with elevated prolactin -- List of contributors -- Authors' index -- Subject index